Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy

Wen Liu,1 Wenxian Li,1 Zhankun Wang,2 Yao Zhu,3 Dingwei Ye,3 Guiming Zhang1 1Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, People’s Republic of China; 2Department of Urology, Qingdao Eighth People’s Hospital, Qingdao, People’s Republic o...

Full description

Bibliographic Details
Main Authors: Liu W, Li W, Wang Z, Zhu Y, Ye D, Zhang G
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/metabolically-abnormal-obesity-increases-the-risk-of-advanced-prostate-peer-reviewed-article-CMAR
_version_ 1818853373735075840
author Liu W
Li W
Wang Z
Zhu Y
Ye D
Zhang G
author_facet Liu W
Li W
Wang Z
Zhu Y
Ye D
Zhang G
author_sort Liu W
collection DOAJ
description Wen Liu,1 Wenxian Li,1 Zhankun Wang,2 Yao Zhu,3 Dingwei Ye,3 Guiming Zhang1 1Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, People’s Republic of China; 2Department of Urology, Qingdao Eighth People’s Hospital, Qingdao, People’s Republic of China; 3Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of ChinaCorrespondence: Guiming ZhangDepartment of Urology, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Qingdao 266003, People’s Republic of ChinaTel +86-532 82913056Fax +86-532 82911999Email zhangguiming9@126.comBackground: To investigate the pathological risk of prostate cancer (PCa) according to the obesity and metabolic status of Chinese patients undergoing radical prostatectomy.Materials and Methods: We performed a retrospective cross-sectional study of 1016 patients with PCa who underwent radical prostatectomy and whose metabolic status and body mass index were examined. Multivariate logistic regression analysis was performed to examine the relationship between different metabolic obesity phenotypes and the pathological outcomes of PCa.Results: Among 1016 men, 551 (54.2%), 106 (10.4%), 238 (23.4%), and 121 (11.9%) were assigned to the metabolically healthy and normal weight (MHNW) group, metabolically abnormal but normal weight (MANW) group, metabolically healthy but overweight or obese (MHO) group, and metabolically abnormal and overweight or obese (MAO) group, respectively. Compared with the MHNW group, the MAO group had a significantly greater risk of a higher prostatectomy Gleason score [odds ratio (OR), 1.907; 95% confidence interval (95% CI), 1.144– 3.182], pathological stage (OR, 1.606; 95% CI, 1.035– 2.493), and seminal vesicle invasion (OR, 1.673; 95% CI, 1.041– 2.687). In contrast, the ORs were not increased in the MHO or MANW group. In the context of normal weight, metabolic disorders were associated with lymph node involvement. The metabolic status and body mass index were not associated with extracapsular extension or surgical margins in any of the four groups.Conclusion: The MAO phenotype is associated with aggressive PCa, including a higher prostatectomy Gleason score, pathological stage, and seminal vesicle invasion and might also be associated with disease progression. Obesity and metabolic disorders act synergistically to increase the pathological risk of PCa.Keywords: prostate cancer, obesity, metabolic syndrome, pathology, Gleason score
first_indexed 2024-12-19T07:35:47Z
format Article
id doaj.art-f48652c0b12c4542905b029bd8aa0f00
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-19T07:35:47Z
publishDate 2020-03-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-f48652c0b12c4542905b029bd8aa0f002022-12-21T20:30:36ZengDove Medical PressCancer Management and Research1179-13222020-03-01Volume 121779178752391Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical ProstatectomyLiu WLi WWang ZZhu YYe DZhang GWen Liu,1 Wenxian Li,1 Zhankun Wang,2 Yao Zhu,3 Dingwei Ye,3 Guiming Zhang1 1Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, People’s Republic of China; 2Department of Urology, Qingdao Eighth People’s Hospital, Qingdao, People’s Republic of China; 3Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of ChinaCorrespondence: Guiming ZhangDepartment of Urology, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Qingdao 266003, People’s Republic of ChinaTel +86-532 82913056Fax +86-532 82911999Email zhangguiming9@126.comBackground: To investigate the pathological risk of prostate cancer (PCa) according to the obesity and metabolic status of Chinese patients undergoing radical prostatectomy.Materials and Methods: We performed a retrospective cross-sectional study of 1016 patients with PCa who underwent radical prostatectomy and whose metabolic status and body mass index were examined. Multivariate logistic regression analysis was performed to examine the relationship between different metabolic obesity phenotypes and the pathological outcomes of PCa.Results: Among 1016 men, 551 (54.2%), 106 (10.4%), 238 (23.4%), and 121 (11.9%) were assigned to the metabolically healthy and normal weight (MHNW) group, metabolically abnormal but normal weight (MANW) group, metabolically healthy but overweight or obese (MHO) group, and metabolically abnormal and overweight or obese (MAO) group, respectively. Compared with the MHNW group, the MAO group had a significantly greater risk of a higher prostatectomy Gleason score [odds ratio (OR), 1.907; 95% confidence interval (95% CI), 1.144– 3.182], pathological stage (OR, 1.606; 95% CI, 1.035– 2.493), and seminal vesicle invasion (OR, 1.673; 95% CI, 1.041– 2.687). In contrast, the ORs were not increased in the MHO or MANW group. In the context of normal weight, metabolic disorders were associated with lymph node involvement. The metabolic status and body mass index were not associated with extracapsular extension or surgical margins in any of the four groups.Conclusion: The MAO phenotype is associated with aggressive PCa, including a higher prostatectomy Gleason score, pathological stage, and seminal vesicle invasion and might also be associated with disease progression. Obesity and metabolic disorders act synergistically to increase the pathological risk of PCa.Keywords: prostate cancer, obesity, metabolic syndrome, pathology, Gleason scorehttps://www.dovepress.com/metabolically-abnormal-obesity-increases-the-risk-of-advanced-prostate-peer-reviewed-article-CMARprostate cancerobesitymetabolic syndromepathologygleason score
spellingShingle Liu W
Li W
Wang Z
Zhu Y
Ye D
Zhang G
Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy
Cancer Management and Research
prostate cancer
obesity
metabolic syndrome
pathology
gleason score
title Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy
title_full Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy
title_fullStr Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy
title_full_unstemmed Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy
title_short Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy
title_sort metabolically abnormal obesity increases the risk of advanced prostate cancer in chinese patients undergoing radical prostatectomy
topic prostate cancer
obesity
metabolic syndrome
pathology
gleason score
url https://www.dovepress.com/metabolically-abnormal-obesity-increases-the-risk-of-advanced-prostate-peer-reviewed-article-CMAR
work_keys_str_mv AT liuw metabolicallyabnormalobesityincreasestheriskofadvancedprostatecancerinchinesepatientsundergoingradicalprostatectomy
AT liw metabolicallyabnormalobesityincreasestheriskofadvancedprostatecancerinchinesepatientsundergoingradicalprostatectomy
AT wangz metabolicallyabnormalobesityincreasestheriskofadvancedprostatecancerinchinesepatientsundergoingradicalprostatectomy
AT zhuy metabolicallyabnormalobesityincreasestheriskofadvancedprostatecancerinchinesepatientsundergoingradicalprostatectomy
AT yed metabolicallyabnormalobesityincreasestheriskofadvancedprostatecancerinchinesepatientsundergoingradicalprostatectomy
AT zhangg metabolicallyabnormalobesityincreasestheriskofadvancedprostatecancerinchinesepatientsundergoingradicalprostatectomy